Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28

Benzinga Newsdesk www.benzinga.com Positive 36.5%

Neg 0% Neu 0% Pos 36.5%

Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.